Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Sunday, December 20, 2009, 8:22AM ET - U.S. Markets Closed. Dow Up 0.20% Nasdaq Up 1.45%
Heska Corp. (HSKA)On Dec 18: 0.4301  Down 0.0209 (4.63%)  
MORE ON HSKA
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials

ProfileGet Profile for:
Heska Corp.
3760 Rocky Mountain Avenue
Loveland, CO 80538
United States - Map
Phone: 970-493-7272
Fax: 970-619-3003
Web Site: http://www.heska.com

DETAILS 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:312

BUSINESS SUMMARY 
Heska Corporation develops, manufactures, markets, sells, and supports veterinary products for the canine and feline companion animal health markets. It operates in two segments, Core Companion Animal Health; and Other Vaccines, Pharmaceuticals, and Products. The Core Companion Animal Health segment offers veterinary diagnostic and other instruments, including handheld blood analyzers, veterinary chemistry analyzers, veterinary hematology analyzers, IV pumps, and consumable supplies; point-of-care diagnostic and other tests, such as heartworm diagnostic tests for dogs and cats, and early renal damage detection products; and veterinary diagnostic laboratory products and services, which comprise allergy diagnostic products and services, as well as ERD Reagent Packs used to detect microalbuminuria. It provides pharmaceuticals and supplements, such as heartworm prevention products, nutritional supplements, and hypothyroid treatment products; and vaccines and other biologicals for the treatment of allergies and feline respiratory diseases. This segment sells its products to veterinarians directly, as well as through telephone sales force, independent third party distributors, and other distribution relationships. The Other Vaccines, Pharmaceuticals, and Products segment provides private label vaccines and pharmaceuticals primarily for cattle, as well as for other animals, including small mammals and fish. It offers bovine vaccines, and biological and pharmaceutical products for other animal health companies, as well as provides turnkey services, which consist of research, licensing, production, labeling, and packaging of products, as well as validation support and distribution services. This segment sells its products through third parties under third party labels. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. Heska Corporation was founded in 1988 and is headquartered in Loveland, Colorado.
Key Statistics

COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on Heska Corp.


    CORPORATE GOVERNANCE 
    Heska Corp.'s Corporate Governance Quotient (CGQ®) as of 1-Dec-09 is better than 94.2% of CGQ Universe companies and 83.1% of Pharmaceuticals, Biotechnology & Life Sciences companies.
    Brought to you by Institutional Shareholder Services.

    KEY EXECUTIVES 
     PayExercised
    Dr. Robert B. Grieve Ph.D., 57
    Co-Founder, Chairman and Chief Exec. Officer
    $ 416.00K $ 0
    Dr. Michael J. McGinley Ph.D., 48
    Pres and Chief Operating Officer
    $ 194.00K $ 0
    Mr. Jason A. Napolitano , 40
    Chief Financial Officer, Exec. VP and Sec.
    $ 241.00K $ 0
    Mr. Michael A. Bent , 54
    Principal Accounting Officer, VP and Controller
    $ 170.00K $ 0
    Mr. G. Lynn Snodgrass , 39
    VP of Sales
    $ 210.00K $ 0
    Dollar amounts are as of 31-Dec-08 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
    Get Profile for Another Symbol: Symbol Lookup
    Annual ReportsSector Analysis